SCHEMBL8212003

SCHEMBL8212003

O=C(Nc1ccccn1)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.81
▸ KMT2A Q03164 6/20 0.81
▸ LMNA P02545 2/20 0.81
▸ NPC1 O15118 9/20 0.76
▸ RAB9A P51151 8/20 0.76
▸ SMN1; SMN2 Q16637 4/20 0.76
▸ MAPT P10636 3/20 0.76
▸ STAT1 P42224 1/20 0.76
▸ ALDH1A1 P00352 2/20 0.64
▸ TP53 P04637 1/20 0.64
▸ TDP1 Q9NUW8 1/20 0.60
▸ F2 P00734 1/20 0.59
▸ ADORA3 P0DMS8 1/20 0.59
▸ KDR P35968 1/20 0.59
▸ HPGD P15428 1/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ MITF O75030 1/20 0.57
▸ POLB P06746 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ OPRK1 P41145 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2977443 0.87 KMT2A (0.71) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL10090737 0.85 ALDH1A1 (0.78) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL6026321 0.84 MEN1 (0.64) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL21616930 0.83 KDR (0.63) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL16899268 0.82 KMT2A (0.72) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL30485791 0.82 NPC1 (0.80) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL22232687 0.82 NPC1 (0.80) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL8306021 0.82 RAB9A (0.63) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL11828548 0.81 ALDH1A1 (0.74) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL997866 0.81 RAB9A (0.89) MEN1KMT2ALMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3094621-A1 ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS Council of Scientific & Industrial Research (IN) 2016-11-23 — — EP claimed
WO-2015104722-A1 ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-07-16 — — WO claimed
WO-2011004393-A2 PARA AMINO BENZOIC ACID BASED NANOTUBES INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY (IN) 2011-01-13 — — WO claimed
CN-112703183-B Aryl-N-aryl derivatives for the treatment of RNA viral infections ABIVAX公司 2025-06-10 — — CN disclosed
US-11739073-B2 Aryl-n-aryl derivatives for treating a RNA virus infection ABIVAX (FR) 2023-08-29 — — US disclosed
US-11739073-B2 Aryl-n-aryl derivatives for treating a RNA virus infection ABIVAX (FR) 2023-08-29 — — US disclosed
US-20210300871-A1 ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION ABIVAX (FR) 2021-09-30 — — US disclosed
EP-3820848-A1 ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION ABIVAX (FR) 2021-05-19 — — EP disclosed
CN-112703183-A aryl-N-aryl derivatives for the treatment of RNA viral infections ABIVAX公司 2021-04-23 — — CN disclosed
EP-3392240-B1 USE OF N-(PYRIDIN-2-YL)-AMIDE AND PHENYL-UREA DERIVATIVES FOR TERAHERTZ TAGGING APPLICATIONS COUNCIL SCIENT IND RES (IN) 2020-06-03 — — EP disclosed
EP-3392240-B1 USE OF N-(PYRIDIN-2-YL)-AMIDE AND PHENYL-UREA DERIVATIVES FOR TERAHERTZ TAGGING APPLICATIONS COUNCIL SCIENT IND RES (IN) 2020-06-03 — — EP disclosed
US-20160335827-A1 ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-11-17 — — US disclosed
US-20160335827-A1 ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-11-17 — — US disclosed
WO-2015104722-A1 ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-07-16 — — WO disclosed
US-20130052137-A1 PARA AMINO BENZOIC ACID BASED NANOTUBES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2013-02-28 — — US disclosed
US-20130052137-A1 PARA AMINO BENZOIC ACID BASED NANOTUBES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2013-02-28 — — US disclosed
US-20130052137-A1 PARA AMINO BENZOIC ACID BASED NANOTUBES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2013-02-28 — — US disclosed
WO-2011004393-A2 PARA AMINO BENZOIC ACID BASED NANOTUBES INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY (IN) 2011-01-13 — — WO disclosed
WO-2011004393-A2 PARA AMINO BENZOIC ACID BASED NANOTUBES INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY (IN) 2011-01-13 — — WO disclosed
US-4044147-A N-(acyl)-p-amino-N'-(monosubstituted)-benzamide anti-ulcer agents PFIZER INC. (US) 1977-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300871-A1 ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION HAVCR2, CBR3, C1R MEN1 3433/4885KMT2A 2616/4885LMNA 2454/4885
US-20160335827-A1 ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS WIZ, CRYZ, NAA15 MEN1 2255/4885KMT2A 1560/4885LMNA 4313/4885
US-20130052137-A1 PARA AMINO BENZOIC ACID BASED NANOTUBES PHB2, TBCA, SLC43A1 MEN1 4704/4885KMT2A 683/4885LMNA 103/4885
US-11739073-B2 Aryl-n-aryl derivatives for treating a RNA virus infection HAVCR2, CBR3, C1R MEN1 3433/4885KMT2A 2616/4885LMNA 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback